James A Schoeneck Insider Trading
Get free email notifications about insider trading for James A Schoeneck.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James A Schoeneck. James A Schoeneck is a Director in DEPOMED INC ($DMI) and a President and CEO in DEPOMED INC ($DMI) and a Director in FIBROGEN INC ($FGEN) and a Interim CEO in FIBROGEN INC ($FGEN) and a Interim President in FIBROGEN INC ($FGEN) and a Director in ANAPTYSBIO INC ($ANAB).
Address: C/O DEPOMED 1360 O'BRIEN DR. MENLO PARK 94025 CA
Companies in which James A Schoeneck is an Insider
ANAPTYSBIO, INC
Trading Symbol: ANABIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James A Schoeneck: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 06 2018
$ANAB Market Capitalization: $365.89M
$ANAB Previous Close: $18.54
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Assertio Therapeutics, Inc
Trading Symbol: DMIIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James A Schoeneck: President and CEO, Director
Holdings: 0 shares
Latest Transaction: Feb 10 2017
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
FIBROGEN INC
Trading Symbol: FGENIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James A Schoeneck: Interim President, Interim CEO, Director
Holdings: 14,100 shares
Current Value: $336,990
Latest Transaction: May 28 2021
$FGEN Market Capitalization: $1.47B
$FGEN Previous Close: $23.90
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of James A Schoeneck
Sentiment: All, ANAB, DMI, FGEN
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 28 2021 | FGEN | FIBROGEN INC | Schoeneck James A | Director | Option Exercise | A | 20.86 | 7,800 | 162,708 | 7,800 | |
May 28 2021 | FGEN | FIBROGEN INC | Schoeneck James A | Director | Grant | A | 0.00 | 4,700 | 0 | 14,100 | 9.4 K to 14.1 K (+50.00 %) |
Jan 06 2021 | FGEN | FIBROGEN INC | Schoeneck James A | Director | Option Exercise | M | 9.78 | 6,000 | 58,650 | 0 | |
Jan 06 2021 | FGEN | FIBROGEN INC | Schoeneck James A | Director | Buy | M | 9.78 | 6,000 | 58,650 | 15,400 | 9.4 K to 15.4 K (+63.83 %) |
Aug 21 2020 | FGEN | FIBROGEN INC | Schoeneck James A | Director | Option Exercise | M | 5.95 | 6,000 | 35,700 | 0 | |
Aug 21 2020 | FGEN | FIBROGEN INC | Schoeneck James A | Director | Buy | M | 5.95 | 6,000 | 35,700 | 15,400 | 9.4 K to 15.4 K (+63.83 %) |
Jun 08 2020 | FGEN | FIBROGEN INC | Schoeneck James A | Director | Option Exercise | A | 32.69 | 7,800 | 254,982 | 7,800 |